SMTL ID : 6r12.3 (2 other biounits)

Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex with compound 7b

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.74 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.25, C.28, C.91, C.94 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.25, A:C.28, A:C.91, A:C.94

1 x EF2: S-Thalidomide(Non-covalent)

EF2.2: 9 residues within 4Å: Chain A: N.51, P.52, F.57, F.78, S.79, W.80, W.86, W.100, Y.102 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:N.51, A:W.80, A:W.100, A:W.100 Hydrogen bonds: A:F.78, A:W.80

1 x UNK- UNK- UNK- UNK- UNK: Cereblon isoform 4(Non-covalent)

UNK-UNK-UNK-UNK-UNK.3: 6 residues within 4Å: Chain A: M.41, H.47, W.80, F.81, K.82, Y.84 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:H.47, A:F.81, A:Y.84 Hydrogen bonds: A:K.82

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heim, C. et al., De-Novo Design of Cereblon (CRBN) Effectors Guided by Natural Hydrolysis Products of Thalidomide Derivatives. J.Med.Chem. (2019)

Release Date

2019-08-07

Peptides

Cereblon isoform 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Cereblon isoform 4

Related Entries With Identical Sequence